Eczema, or atopic dermatitis, often worsens during seasonal changes like monsoon and autumn. Fluctuating humidity, allergens, ...

Eczema is a chronic condition, causing skin to crack up and be itchy. Know what makes you vulnerable to this skin condition.

Shares in French drugmaker Sanofi ($SNY) sickened today as trial data on a new eczema treatment disappointed investors. Met ...

If you or someone you love has eczema, you know treating it can be frustrating. It takes a lot of trial and error to f ...

Data from the late-stage trial of amlitelimab weren’t as strong as the results seen in Phase 2, adding to doubts about a drug ...

Noa Therapeutics (Noa), a Toronto-based biotechnology company pioneering a biased engagement approach to the aryl hydrocarbon ...

HeySunday breaks down how seemingly harmless household products can contribute to eczema symptoms and what you can do to make ...

Anyone can have eczema, though CDC data shows that it’s disproportionately diagnosed in women. This complex condition is strongly linked to allergies, asthma, and other autoimmune issues. Common ...

Amlitelimab showed efficacy in skin clearance and disease severity compared to placebo in a phase 3 study with adolescent and ...

Exercising with eczema needs care. Sweat, friction, and heat can trigger flare-ups. Opt for breathable fabrics, short ...

Eczema can be very distressing for children – and now it seems that its roots may at least partly lie in their mothers ...

Shares in French drugmaker Sanofi fell more than 10% on Thursday, wiping nearly $13 billion off its market value, after ...